Back
Inhibrx Biosciences 10K Form
Sell
34
INBX
Inhibrx Biosciences
Last Price:
$15.28
Seasonality Move:
--
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive INBX News And Ratings
See the #1 stock for the next 7 days that we like better than INBX
INBX Financial Statistics
Sales & Book Value
| Annual Sales: | $1.6M |
|---|---|
| Cash Flow: | $-30.5M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $12.33 |
| Price / Book: | 1.25 |
Profitability
| EPS (TTM): | 118.67400 |
|---|---|
| Net Income (TTM): | $1.8B |
| Gross Margin: | -- |
| Return on Equity: | 2616.46% |
| Return on Assets: | 1679% |
Inhibrx Biosciences Earnings Forecast
Key Inhibrx Biosciences Financial Ratios
-
The Research & Development expenses have been 7,964.08% of Revenue.
-
The Net Earning history of INBX is -9,483.72% of Total Revenues.
-
Per Share Earnings over the last 2 years have been positive in 0 years.
Inhibrx Biosciences Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | INBX |
| Website: | inhibrx.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 6.2 |
| Quick Ratio: | 5.84 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
INBX Technical Analysis vs Fundamental Analysis
Sell
34
Inhibrx Biosciences (INBX)
is a Sell
Is Inhibrx Biosciences a Buy or a Sell?
-
Inhibrx Biosciences stock is rated a SellThe current Inhibrx Biosciences [INBX] share price is $15.40. The Score for INBX is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.